Supplemental data:

ACE-Inhibitor or AT2-Antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations

C. Mitterbauer1, G. Heinze2, A. Kainz1,3, W.H. Hörl1, R. Oberbauer1,3

1- Department of Nephrology, Medical University of Vienna, Austria
2- Core Unit of Medical Statistics and Informatics, Medical University of Vienna, Austria
3- Department of Nephrology, KH Elisabethinen, Linz, Austria


All supplemental data are available for downloaded as a single PDF document.

TABLES
FIGURES
Webtable 1 Webtable 1

Assessment of working correlation structure

Webfigure 1 Webfigure 1

Boxplot of potassium levels vs. year after engraftment, stratified for ACEI/ARB use.

Webtable 2 Webtable 2

Mixed linaer model with “sticky” group definition

Webfigure 2 Webfigure 2

Number of ACEI/ARB user/nonusers vs. year after engraftment.

Webtable 3 Webtable 3

Testing for interaction between ACEI/ARB and year of use (sticky group definition)

Webfigure 3 Webfigure 3

Percentage of ACEI/ARB user/nonuser vs. year after engraftment.

Webtable 4 Webtable 4

Mixed linaer model without ACEI/ARB changers.
Subjects who switched groups were eliminated as suggested by the reviewer. The results are materially identical to the other models presented above and in the manuscript in table 3.

Webfigure 4 Webfigure 4

Residual diagnostics

Webtable 5 Webtable 5

Test for interaction of ACEI/ARB and CNI use

Webfigure 5a/b   Webfigure 5c/d Webfigure 5 a,b c, d

a,b: Residuals against predicted values

c,d: Absolute residuals against predicted values (to detect heteroscedasticity)